Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sarah Nemec currently holds 17,082 shares of Bolt Biotherapeutics, Inc. (BOLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Nemec has been a net seller of BOLT stock. They have purchased $2.7K and sold $26.1K worth of shares.
Sarah Nemec's most recent insider trade was on Sep 18, 2026, when they sold 4,077 shares at $3.24 per share.
Sarah Nemec serves as Executive at Bolt Biotherapeutics, Inc. (BOLT). They have executed 8 insider transactions totaling $28.7K over their tenure at the company.
Sarah Nemec holds the position of Executive at Bolt Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Sarah Nemec has shown a selling trading pattern, with $2.7K in total purchases and $26.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sarah Nemec was on Sep 18, 2026, when they sold $13.2K worth of BOLT shares. This transaction involved 4,077 shares at $3.24 per share.
Sarah Nemec currently owns 17,082 shares of Bolt Biotherapeutics, Inc. (BOLT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sarah Nemec's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sarah Nemec has 8 Form 4 filings on record as an insider at Bolt Biotherapeutics, Inc..
Set alerts for Sarah Nemec and 40,000+ other insiders.